Earnings Release • Nov 28, 2019
Earnings Release
Open in ViewerOpens in native device viewer


• On November 15, Elekta published preliminary results for the second quarter and updated outlook of EBITA margin from around 19 percent, to around 18 percent, for fiscal year 2019/20.
| Q2 | First six months | |||||
|---|---|---|---|---|---|---|
| SEK M | 2019/20 | 2018/19 | Δ | 19/20 | 18/19 | Δ |
| Gross order intake | 4,036 | 3,670 | 3 5% |
8,426 | 6,844 | 17% |
| Net sales | 3,709 | 3,330 | 3 7% |
6,937 | 6,149 | 8% |
| Gross margin | 41.0% | 41.4% | -0,4 ppts | 41.7% | 40.3% | 1,4 ppts |
| EBITA | 539 | 601 | -10% | 987 | 987 | 0% |
| EBITA margin | 14.5% | 18.0% | -3,5 ppts | 14.2% | 16.0% | -1,8 ppts |
| EBIT | 321 | 393 | -18% | 556 | 631 | -12% |
| Cash flow 1 | 234 | 367 | -36% | -550 | -175 | -214% |
| Earnings per share, SEK2 | 0.58 | 0.75 | -23% | 0.96 | 1.18 | -18% |
1 After continuous investments
2 Before / after dilution
3 Compared to last fiscal year based on constant exchange rates
This is information is such that Elekta AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication by the below mentioned contact persons at 07:30 CET on November 28, 2019. (REGMAR)
Forward-looking information. This report included forward-looking statements including, but not limited to, statements relation to operational and financial performance, market conditions, and other similar matters. These forward-looking statements are based on current expectations about future events. Although the expectations described in these statements are assumed to be reasonable, there is no guarantee that such forward-looking statements will materialize or are accurate. Since these statements involve assumptions and estimates that are subject to risks and uncertainties, results could differ materially from those set out in the statement. Some of these risks and uncertainties are described further in the section "Risk and uncertainties". Elekta undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, whether as a result of new information, future events or otherwise, except as required by law or stock exchange regulations.
We delivered mixed outcomes in the second quarter. Order growth was very strong in emerging markets and North America. Some delayed installations hampered our revenue growth and profitability, although the largest negative impact on profitability came from exchange rate differences.
The order intake in the second quarter was very strong in North & South America as well as in Asia Pacific. Other emerging markets – such as the Middle East & Africa – also reported strong order growth. Europe had a weak quarter. Looking at the half-year growth rates we had double-digit growth numbers in all regions, reflecting the fluctuations between quarters.
Elekta Unity as well as brachytherapy supported the strong development in our order books.
Overall our installed base of treatment solutions was growing by 8 percent, which ensures good recurrent business in the future. Five Unity systems went clinical in the quarter. The high attractiveness of Elekta Unity was confirmed at ASTRO, with very strong interest from customers and Elekta Unity being subject to many studies presented throughout the conference. MOSAIQ® Plaza got very positive feedback with customers stating that it is adding intelligence to value based health care.
Our profitability in the quarter decreased due to a substantial headwind from currency changes and delayed start of installations. Foreign exchange had a negative impact on the EBITA margin of around 200 basis points. Our EBITA was also affected by a shortfall of Leksell Gamma Knife installations, which had in total a negative impact of approximately 150 basis points. With an already strong installation plan for the coming six months we do not expect to be able to fully recover the delayed installation this fiscal year and therefore lowered our EBITA guidance for 2019/20 earlier in November.
Our Brexit mitigation stock at the end of October increased inventory. With a reduced risk of a hard Brexit we will work this down over the next two quarters.
We continued to take steps in Precision Radiation Medicine in the quarter, e.g. by strengthening our cloud-based software offerings through the acquisition of ProKnow. We are focused on driving the MR-linac paradigm shift in radiation therapy to ensure broad market adoption for the benefit of patients, customers, and Elekta.
Richard Hausmann President and CEO

6 new Elekta Unity orders
UMC Utrecht has installed a second MR-Linac solely dedicated to prostate cancer treatments
Gross order intake increased by 10 percent to SEK 4,036 M (3,670) and 5 percent based on constant exchange rates.
Order backlog was SEK 33,581 M, compared to SEK 32,003 M on April 30, 2019. Order backlog is converted at closing exchange rates, which resulted in a positive translation difference of SEK 334 M.
| Q2 | First six months | |||||||
|---|---|---|---|---|---|---|---|---|
| SEK M | 2019/20 2018/19 | 1 Δ |
1 Δ |
2019/20 | 2018/19 | 1 Δ |
Δ | |
| North and South | ||||||||
| America | 1,202 | 875 | 29% | 37% | 2,265 | 1,865 | 13% | 21% |
| Europe, Middle | ||||||||
| East and Africa | 1,256 | 1,594 | -21% | -21% | 2,965 | 2,598 | 12% | 14% |
| Asia Pacific | 1,579 | 1,202 | 23% | 31% | 3,196 | 2,382 | 26% | 34% |
| Group | 4,036 | 3,670 | 5% | 10% | 8,426 | 6,844 | 17% | 23% |
1 Compared to last fiscal year based on constant exchange rates
With an organic growth rate of 29 percent in the second quarter North and South America had a very good development of its order book. Canada contributed to the order growth as did South American, with new systems demanded from clinics in e.g. Mexico and Colombia.
Two Elekta Unity orders were booked during the quarter, both ordered by UT Southwestern Medical Center in the US.
In the second quarter order intake in Europe, Middle East and Africa decreased as region by -21 percent. The mature markets had some softness and a few, but large bundled deals were lost in the quarter. The development in emerging markets was very good, e.g. in countries such as Saudi Arabia, Morocco, South Africa and Bulgaria.
In this region one order was booked for Elekta Unity during the quarter in Turkey.
Asia Pacific order intake continued the strong growth from the first quarter and reported 23 percent organic growth in the second quarter. India, Singapore and Malaysia had very good growth rates. Also Taiwan showed good order growth throughout the product portfolio, with an extra boost by two Elekta Unity orders. China continued to grow and based on the latest IPSOS data the Chinese market share strengthened further.
Three Elekta Unity systems were ordered in Asia Pacific in the second quarter. In addition to the two Taiwanese orders, Gangnam Severence Hospital in Korea ordered one Elekta Unity.

Gross order intake North and South America



Net sales increased to SEK 3,709 M (3,330) in the second quarter, representing a growth of 11 percent or 7 percent based on constant exchange rates. The organic net sales showed good growth in Europe, Middle East and Africa as well as in Asia Pacific, whereas the development in North and South America was stable.
| Q2 | First six months | |||||||
|---|---|---|---|---|---|---|---|---|
| SEK M | 2019/20 | 2018/19 | 1 Δ |
Δ | 2019/20 | 2018/19 | 1 Δ |
Δ |
| North and South America Europe, Middle |
1,208 | 1,115 | 1% | 8% | 2,218 | 2,052 | 1% | 8% |
| East and Africa |
1,390 | 1,290 | 8% | 8% | 2,548 | 2,292 | 10% | 11% |
| Asia Pacific | 1,111 | 925 | 13% | 20% | 2,171 | 1,804 | 14% | 20% |
| Group | 3,709 | 3,330 | 7% | 11% | 6,937 | 6,149 | 8% | 13% |
1 Compared to last fiscal year based on constant exchange rates
In the second quarter net sales had a stable development in North and South America in local currencies. However, the US showed good growth as well as Mexico and Brazil in the South American market.
In Europe, Middle East and Africa sales growth at constant exchange rates reached 8 percent in the second quarter. A good pace of installations in countries such as Turkey, South Africa and Egypt led to a strong sales development in emerging markets, whereas the business in mature European markets were modest.
The Asia Pacific region had a good development in the second quarter with 13 percent growth rate based on constant currencies. Strong double-digit sales growth came from among others India, Indonesia, Korea and Taiwan. China also reported a strong growth rate of 20 percent.
7% organic net sales growth

Emerging markets showed strong growth rates
In the first six months net sales grew by 8 percent in constant currencies. Solutions had a good development with an organic growth rate of 9 percent, driven by the linac business. In the second quarter delayed installations of Leksell Gamma Knife units had a negative impact on net sales of Solutions. Services grew by 7 percent resulting from ongoing focus on customer relations and service excellence.
| Q2 | First six months | |||||||
|---|---|---|---|---|---|---|---|---|
| SEK M | 2019/20 | 2018/19 | 1 Δ |
Δ | 2019/20 | 2018/19 | 1 Δ |
Δ |
| Solutions | 2,249 | 2,054 | 6% | 9% | 4,107 | 3,636 | 9% | 13% |
| Service | 1,460 | 1,276 | 8% | 14% | 2,831 | 2,513 | 7% | 13% |
| Total | 3,709 | 3,330 | 7% | 11% | 6,937 | 6,149 | 8% | 13% |
1 Compared to last fiscal year based on constant exchange rates
Gross margin was 41.7 percent (40.3) in the period. The increase compared to last year was due to strong software sales and improved project mix in North and South America.
Operating expenses increased by 6 percent in constant currencies, related to investments in the sales organization to capture market growth and investments in new IT platforms and operational excellence. R&D expenditure, adjusted for the net of capitalization and amortization of R&D costs described below, amounted to SEK 715 M (712), equal to 10 percent (12) of net sales. On a rolling twelve months basis the R&D expenditure to net sales were 10 percent (11).
EBITA was SEK 987 M (987) representing a margin of 14.2 percent (16.0). The decrease in EBITA margin was explained by a negative impact from foreign exchange of SEK -90 M and by one-off gain in the comparing period due to the divestment of the MEG business amounted to SEK 70 M. Operating result (EBIT) was SEK 556 M (631).
Net financial items amounted to SEK -81 M (-53). Interest on lease liabilities under IFRS 16 amounted to SEK -25 M and was the key driver of the change. Profit before tax amounted to SEK 475 M (577) and tax amounted to SEK -107 M (-127), representing a tax rate of 22.5 percent (22.0).
Net income amounted to SEK 368 M (450) and earnings per share amounted to SEK 0.96 (1.18) before/after dilution. Return on shareholders' equity amounted to 15 percent (20) and return on capital employed was 13 percent (16).
Solutions grew by 9%
Improved gross margin to 41.7%
Flat EBITA explained by negative fx impact and one-off gain in comparing period
The net of capitalized development costs in the R&D function decreased to SEK -132 M (-64). This was explained by higher amortization of Elekta Unity post the CE mark. In the second quarter the capitalization increased due to progress of the R&D projects.
| Q2 | First six months | ||||
|---|---|---|---|---|---|
| SEK M | 2019/20 | 2018/19 | 2019/20 | 2018/19 | |
| R&D, net | -51 | -72 | -132 | -64 | |
| Capitalization | 135 | 104 | 236 | 232 | |
| Amortization | -185 | -176 | -368 | -296 | |
| Other, net | -1 | 0 | -2 | 1 | |
| Capitalization | 0 | 0 | 0 | 1 | |
| Amortization | -1 | 0 | -2 | -1 | |
| Total, net | -52 | -72 | -134 | -64 | |
| Capitalization | 135 | 104 | 236 | 233 | |
| Amortization | -187 | -176 | -370 | -297 |
Investments in intangible assets were SEK 238 M (235) and investments in tangible assets were SEK 102 M (70). Amortization of intangible assets and depreciation of tangible fixed assets amounted to a total of SEK 620 M (435). The increase was mainly due to the implementation of IFRS 16, SEK 105 M, and higher amortization of R&D.
Cash flow from operating activities was SEK -210 M (130). Continuous investments increased mainly due to the progress of the R&D projects in the second quarter. Cash flow after continuous investments was SEK -550 M (-175). The decline in cash flow was mainly due to increased levels of net working capital, see Working capital section below.
| Q2 | First six months | ||||
|---|---|---|---|---|---|
| SEK M | 2019/20 | 2018/19 | 2019/20 | 2018/19 | |
| Operating cash flow | 614 | 592 | 1,008 | 910 | |
| Change in w orking capital |
-194 | -81 | -1,218 | -780 | |
| Cash flow from operating | |||||
| activities | 419 | 512 | -210 | 130 | |
| Continuous investments | -185 | -145 | -340 | -305 | |
| Cashflow after continuous | |||||
| investments | 234 | 367 | -550 | -175 | |
| Operational cash conversion | 66% | 80% | -18% | 12% |
Net working capital was SEK -971 M (-1,628) corresponding to SEK -7 (-13) percent of net sales. Inventory increased mainly due to Brexit mitigation measures and the commercialization of Elekta Unity. The increase in other operating receivables came mostly from customer projects. For more information, see page 28.
| SEK M | Oct 31 2019 |
Oct 31 2018 |
Apr 30 2019 |
|---|---|---|---|
| North and South America | -73 | -114 | -74 |
| Europe, Middle East and Africa | 28 | 16 | 2 |
| Asia Pacific | -114 | -107 | -113 |
| Group | -50 | -64 | -59 |
Days Sales Outstanding (DSO) was negative 50 days. The negative change came from Europe, Middle East and Africa, mainly due to lower prepaid income.
Cash and cash equivalents and short-term investments amounted to SEK 3,090 M (3,669) and interest-bearing liabilities amounted to SEK 4,599 M (4,958). Net debt amounted to SEK 1,510 M (1,290). Net debt in relation to EBITDA was 0.55 (0.17 per April 30, 2019).
| Oct 31 | Oct 31 | Apr 30 | |
|---|---|---|---|
| SEK M | 2019 | 2018 | 2019 |
| Long-term interest-bearing liabilities | 3,137 | 4,422 | 3,558 |
| Short-term interest-bearing liabilities | 1,462 | 536 | 1,000 |
| Cash and cash equivalents and short-term | |||
| investments | -3,090 | -3,669 | -4,119 |
| Net debt | 1,510 | 1,290 | 439 |
| Long-term leasing liabilities1 | 1,038 | - | - |
| Short-term leasing liabilities1 | 217 | - | - |
| Net debt including leasing liabilities | 2,764 | n/a | n/a |
1 For more information regarding leasing effects, see balance sheet on page 14 and accounting principles on page 18
The exchange rate effect from the translation of cash and cash equivalents amounted to SEK 17 M (53). The translation difference in interest-bearing liabilities amounted to SEK 25 M (47). Other comprehensive income was affected by exchange rate differences from translation of foreign operations amounting to SEK 82 M (-26).
The change in unrealized exchange rate effects from effective cash flow hedges reported in other comprehensive income amounted to SEK 14 M (-187). The closing balance of unrealized exchange rate effects from effective cash flow hedges amounted to SEK -56 M (-154) exclusive of tax.


Elekta's presence in a large number of geographical markets exposes the Group to political and economic risks on a global scale and/or in individual countries. For more details, please see Annual Report 2018/19, page 55.
During the second quarter the executive management team have been extended with two new members. Verena Schiller has been appointed President Neuro Solutions to further develop the neuro business. Lionel Hadjadjeba has been hired and appointed President MR-Linac Solutions to drive the commercialization of Elekta Unity.
On September 5, 2019, Elekta closed an exclusive distribution agreement with DOSIsoft for distribution of key patient-specific QA solutions. DOSIsoft's three QA products completes Elekta's QA portfolio - a comprehensive suite of easy-to-use, web-based tools - positioning Elekta as a single-source provider of QA software.
On September 16, 2019 Elekta signed a sole source agreement with Premier, a leading US healthcare improvement company uniting approximately 4,000 hospitals in the US. The agreement allows Premier's members to take advantage of pre-negotiated special pricing and terms for linacs, Elekta Unity MR-linacs, oncology informatics and services.
During the second quarter Elekta acquired ProKnow Systems, LLC, to expand the offering of cloud-based solutions for advanced radiation therapy. ProKnow's product portfolio enable clinics to standardize their treatment planning analytics by supporting oncology teams with analysis of collective, big data from patient groups. This solution can also streamline workflow challenges and improve contouring accuracy and treatment plan quality.
Find more detailed information about our policies in the Annual Report 2018/19
Awards won in the second quarter:


1 For more details about the previous significant events please see respective quarterly report.
As communicated in November 2015 Elekta's subsidiary in Italy and some former employees are suspected of interfering with public procurement processes. The case has been referred to trial, which is expected to start in February 2020.
As earlier reported humediQ GmbH initiated a new arbitration against Elekta group companies arising out of the same agreement as the previous arbitration in 2016. The hearing in the arbitration took place in October 2019 and the award is expected in the coming months.
The average number of employees during the period was 3,988 (3,696). The average number of employees in the Parent Company was 40 (35).
Total number of registered shares on October 31, 2019 was 383,568,409 of which 14,980,769 were A-shares and 368,587,640 B-shares. On October 31, 2019 1,485,289 shares were treasury shares held by Elekta.
2 The material legal disputes reported here are either new cases or previous cases with changes in the interim period. For previous reported cases please see Elekta's Annual reports.
The Board of Directors and CEO declare that the undersigned interim report provides a fair overview of the parent company's and Group's operations, their financial position and performance, and describes material risks and uncertainties facing the parent company and other companies in the Group.
Stockholm, November 28, 2019
Laurent Leksell Chairman of the board Wolfgang Reim Member of the board
Caroline Leksell Cooke Member of the board
Johan Malmquist Member of the board
Jan Secher Member of the board Birgitta Stymne Göransson Member of the board
Tomas Puusepp Member of the board Cecilia Wikström Member of the board
Richard Hausmann CEO and President

Elekta AB (publ), corporate identity number 556170-4015
Box 7593 103 93 STOCKHOLM
We have reviewed the condensed interim report for Elekta AB (publ) as at October 31, 2019 and for the six-months period then ended. The Board of Directors and the Managing Director are responsible for the preparation and presentation of this interim report in accordance with IAS 34 and the Swedish Annual Accounts Act. Our responsibility is to express a conclusion on this interim report based on our review.
We conducted our review in accordance with the International Standard on Review Engagements, ISRE 2410 Review of Interim Financial Statements Performed by the Independent Auditor of the Entity. A review consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing and other generally accepted auditing standards in Sweden. The procedures performed in a review do not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.
Based on our review, nothing has come to our attention that causes us to believe that the interim report is not prepared, in all material respects, in accordance with IAS 34 and the Swedish Annual Accounts Act regarding the Group, and in accordance with the Swedish Annual Accounts Act regarding the Parent Company.
Stockholm, November 28 2019
Ernst & Young AB
Rickard Andersson Authorized Public Accountant
| Q2 | 6 months | 12 months | May - Apr | |||
|---|---|---|---|---|---|---|
| SEK M | 2019/20 | 2018/19 | 2019/20 | 2018/19 | rolling | 2018/19 |
| Net sales | 3,709 | 3,330 | 6,937 | 6,149 | 14,343 | 13,555 |
| Cost of products sold | -2,188 | -1,953 | -4,041 | -3,669 | -8,248 | -7,875 |
| Gross income | 1,520 | 1,377 | 2,896 | 2,480 | 6,095 | 5,680 |
| Selling expenses | -360 | -320 | -725 | -644 | -1,377 | -1,296 |
| Administrative expenses | -291 | -237 | -561 | -501 | -1,099 | -1,039 |
| R&D expenses | -416 | -411 | -847 | -776 | -1,664 | -1,592 |
| Other operating income and expenses | -16 | - 8 |
-27 | 57 | -60 | 23 |
| Exchange rate differences | -117 | - 9 |
-179 | 14 | -273 | -80 |
| Operating result | 321 | 393 | 556 | 631 | 1,622 | 1,696 |
| Result from participations in associates | 3 | 3 | 4 | 6 | 1 | 3 |
| Interest income | 18 | 15 | 41 | 33 | 74 | 66 |
| Interest expenses and similar items | -50 | -47 | -108 | -92 | -202 | -186 |
| Interest expenses leasing liabilities | -13 | - | -25 | - | -25 | - |
| Exchange rate differences | 6 | 0 | 7 | 0 | 8 | 2 |
| Profit before tax | 285 | 365 | 475 | 577 | 1,478 | 1,580 |
| Income taxes | -64 | -80 | -107 | -127 | -362 | -382 |
| Net income | 221 | 284 | 368 | 450 | 1,116 | 1,198 |
| Net income attributable to: | ||||||
| Parent Company shareholders | 221 | 285 | 368 | 451 | 1,115 | 1,198 |
| Non-controlling interests | 0 | 0 | 0 | 0 | 1 | 0 |
| Earnings per share before dilution, SEK | 0.58 | 0.75 | 0.96 | 1.18 | 2.92 | 3.14 |
| Earnings per share after dilution, SEK | 0.58 | 0.75 | 0.96 | 1.18 | 2.92 | 3.14 |
| Q2 | 6 months | 12 months | May - Apr | |||
|---|---|---|---|---|---|---|
| SEK M | 2019/20 | 2018/19 | 2019/20 | 2018/19 | rolling | 2018/19 |
| Net income | 221 | 284 | 368 | 450 | 1,116 | 1,198 |
| Other comprehensive income: | ||||||
| Items that w ill not be reclassified to the income statement: |
||||||
| Remeasurements of defined benefit pension plans | - | - | - | - | - 1 |
- 1 |
| Tax | - | - | 1 | - | 1 | 1 |
| Total items that will not be reclassified to the income | ||||||
| statement | - | - | - 1 |
- | - 1 |
- 1 |
| Items that subsequently may be reclassified to the income | ||||||
| statement: | ||||||
| Revaluation of cash flow hedges |
115 | -109 | 14 | -187 | 100 | -101 |
| Translation differences from foreign operations | 78 | 188 | 82 | -26 | 351 | 243 |
| Tax | -21 | 22 | - 3 |
36 | -20 | 19 |
| Total items that subsequently may be reclassified | ||||||
| to the income statement | 172 | 100 | 93 | -177 | 431 | 161 |
| Other comprehensive income for the period | 172 | 100 | 93 | -177 | 430 | 160 |
| Total comprehensive income for the period | 393 | 384 | 462 | 274 | 1,546 | 1,358 |
| Comprehensive income attributable to: | ||||||
| Parent Company shareholders | 393 | 384 | 461 | 274 | 1,545 | 1,358 |
| Non-controlling interests | 0 | 0 | 0 | 0 | 1 | 0 |
| Result overview | Q2 | 6 months | 12 months | May - Apr | ||
|---|---|---|---|---|---|---|
| SEK M | 2019/20 | 2018/19 | 2019/20 | 2018/19 | rolling | 2018/19 |
| Operating result/EBIT | 321 | 393 | 556 | 631 | 1,622 | 1,696 |
| Amortization: | ||||||
| Capitalized development costs | 187 | 176 | 370 | 297 | 738 | 664 |
| Assets relating to business combinations | 32 | 32 | 60 | 59 | 118 | 117 |
| EBITA | 539 | 601 | 987 | 987 | 2,477 | 2,477 |
| SEK M | Oct 31 2019 |
Oct 31 2018 |
Apr 30 2019 |
|---|---|---|---|
| Non-current assets | |||
| Intangible assets | 9,333 | 9,224 | 9,301 |
| Right-of-use assets | 1,198 | - | - |
| Other tangible fixed assets | 979 | 873 | 957 |
| Financial assets | 606 | 296 | 508 |
| Deferred tax assets | 388 | 356 | 402 |
| Total non-current assets | 12,504 | 10,749 | 11,167 |
| Current assets | |||
| Inventories | 3,048 | 2,463 | 2,634 |
| Accounts receivable | 3,529 | 2,982 | 3,455 |
| Accrued income | 1,356 | 1,420 | 1,401 |
| Current tax assets | 191 | 178 | 158 |
| Derivative financial instruments | 76 | 18 | 72 |
| Other current receivables | 1,447 | 1,166 | 1,059 |
| Short-term investments | 46 | 47 | 45 |
| Cash and cash equivalents | 3,044 | 3,622 | 4,073 |
| Total current assets | 12,736 | 11,895 | 12,897 |
| Total assets | 25,239 | 22,645 | 24,064 |
| Elekta's ow ners' equity |
7,897 | 6,970 | 7,778 |
| Non-controlling interests | 1 | 0 | 1 |
| Total equity | 7,898 | 6,970 | 7,779 |
| Non-current liabilities | |||
| Long-term interest-bearing liabilities | 3,137 | 4,422 | 3,558 |
| Long-term leasing liabilities | 1,038 | - | - |
| Deferred tax liabilities | 584 | 537 | 587 |
| Long-term provisions | 211 | 172 | 188 |
| Other long-term liabilities Total non-current liabilities |
55 5,025 |
84 5,215 |
55 4,388 |
| Current liabilities | |||
| Short-term interest-bearing liabilities | 1,462 | 536 | 1,000 |
| Short-term leasing liabilities | 217 | - | - |
| Accounts payable | 1,270 | 1,111 | 1,427 |
| Advances from customers | 4,777 | 4,652 | 4,883 |
| Prepaid income | 2,065 | 1,910 | 2,170 |
| Accrued expenses | 1,732 | 1,570 | 1,661 |
| Current tax liabilities | 184 | 112 | 166 |
| Short-term provisions | 185 | 157 | 188 |
| Derivative financial instruments | 108 | 153 | 94 |
| Other current liabilities | 316 | 258 | 308 |
| Total current liabilities | 12,315 | 10,460 | 11,897 |
| May - Oct | May - Apr | |||
|---|---|---|---|---|
| SEK M | 2019/20 | 2018/19 | 2018/19 | |
| Attributable to Elekta's owners | ||||
| Opening balance | 7,778 | 6,987 | 6,987 | |
| Opening balance adjustment due to IFRS 15 and IFRS 9 | - | -39 | -39 | |
| Comprehensive income for the period | 461 | 274 | 1,358 | |
| Incentive programs | 1 | 14 | 6 | |
| Dividend | -344 | -267 | -535 | |
| Total | 7,897 | 6,970 | 7,778 | |
| Attributable to non-controlling interests | ||||
| Opening balance | 1 | 0 | 0 | |
| Comprehensive income for the period | 0 | 0 | 0 | |
| Total | 1 | 0 | 1 | |
| Closing balance | 7,898 | 6,970 | 7,779 |
| Q2 | 6 months | 12 months May - Apr | ||||
|---|---|---|---|---|---|---|
| SEK M | 2019/20 | 2018/19 | 2019/20 | 2018/19 | rolling | 2018/19 |
| Profit before tax | 285 | 365 | 475 | 577 | 1,478 | 1,580 |
| Amortization and depreciation | 314 | 246 | 620 | 435 | 1,128 | 943 |
| Interest net | 31 | 22 | 56 | 39 | 108 | 91 |
| Other non-cash items | 81 | 14 | 24 | -29 | 74 | 21 |
| Interest received and paid | -23 | - 7 |
-52 | -44 | -117 | -110 |
| Income taxes paid | -75 | -47 | -116 | -69 | -316 | -269 |
| Operating cash flow | 614 | 592 | 1,008 | 910 | 2,354 | 2,256 |
| Changes in inventories | -150 | 72 | -383 | 30 | -433 | -20 |
| Changes in operating receivables | -101 | -270 | -500 | - 2 |
* -864 |
-367 |
| Changes in operating liabilities | 57 | 118 | -334 | -807 | 224 | -249 |
| Change in w orking capital |
-194 | -81 | -1,218 | -780 | -1,074 | -636 |
| Cash flow from operating activities | 419 | 512 | -210 | 130 | 1,281 | 1,621 |
| Investments intangible assets | -136 | -106 | -238 | -235 | -460 | -458 |
| Investments other assets | -49 | -39 | -102 | -70 | -233 | -201 |
| Sale of fixed assets | 0 | 0 | 0 | 0 | * 0 |
0 |
| Continuous investments | -185 | -145 | -340 | -305 | -693 | -658 |
| Cash flow after continuous investments | 234 | 367 | -550 | -175 | 587 | 962 |
| Changes in short-term investments | 1 | 37 | - 1 |
36 | 1 | 38 |
| Business combinations, divestments and investments in other shares | -79 | -57 | -79 | -47 | -86 | -54 |
| Cash flow after investments | 156 | 347 | -630 | -186 | 502 | 946 |
| Dividends | -344 | -267 | -344 | -267 | -611 | -535 |
| Cash flow from other financing activities |
-42 | 13 | -72 | -436 | -575 | -938 |
| Cash flow for the period | -230 | 93 | -1,046 | -889 | -684 | -527 |
| Change in cash and cash equivalents during the period | ||||||
| Cash and cash equivalents at the beginning of the period | 3,302 | 3,463 | 4,073 | 4,458 | 3,621 | 4,458 |
| Cash flow for the period |
-230 | 93 | -1,046 | -889 | -684 | -527 |
| Exchange rate differences | -28 | 66 | 17 | 53 | 106 | 142 |
| Cash and cash equivalents at the end of the period | 3,044 | 3,622 | 3,044 | 3,622 | 3,044 | 4,073 |
| May - Oct | ||
|---|---|---|
| SEK M | 2019/20 | 2018/19 |
| Operating expenses | -102 | -91 |
| Financial net | 239 | 522 |
| Income after financial items | 136 | 430 |
| Tax | - 1 |
12 |
| Net income | 135 | 442 |
| Statement of comprehensive income | ||
| Net income | 135 | 442 |
| Other comprehensive income | - | - |
| Total comprehensive income | 135 | 442 |
| Oct 31 | Apr 30 | |
|---|---|---|
| SEK M | 2019 | 2019 |
| Non-current assets | ||
| Intangible assets | 57 | 60 |
| Tangible assets | 0 | - |
| Shares in subsidiaries | 2,471 | 2,439 |
| Receivables from subsidaries | 2,398 | 2,393 |
| Other financial assets | 89 | 87 |
| Deferred tax assets | 1 | 3 |
| Total non-current assets | 5,017 | 4,983 |
| Current assets | ||
| Receivables from subsidaries | 3,888 | 3,436 |
| Other current receivables | 68 | 102 |
| Other short-term investments | 46 | 45 |
| Cash and cash equivalents | 1,928 | 2,941 |
| Total current assets | 5,930 | 6,524 |
| Total assets | 10,947 | 11,507 |
| Shareholders' equity | 2,689 | 2,898 |
| Untaxed reserves | 14 | 14 |
| Non-current liabilities | ||
| Long-term interest-bearing liabilities | 3,131 | 3,553 |
| Long-term liabilities to Group companies | - | 0 |
| Long-term provisions | 12 | 12 |
| Total non-current liabilities | 3,143 | 3,565 |
| Current liabilities | ||
| Short-term interest-bearing liabilities | 1,448 | 1,000 |
| Short-term liabilities to Group companies | 3,575 | 3,934 |
| Short-term provisions | 0 | 0 |
| Other current liabilities | 77 | 95 |
| Total current liabilities | 5,100 | 5,029 |
| Total shareholders' equity and liabilities | 10,947 | 11,507 |
This interim report is prepared, with regard to the Group, according to IAS 34 and the Swedish Annual Accounts Act and, with regard to the Parent Company, according to the Swedish Annual Accounts Act and RFR 2. The accounting principles applied are consistent with those presented in Note 1 of the Annual Report 2018/19, with exception for the accounting policies described below.
IFRS 16 is a new standard on accounting for leases which replaces IAS 17 and the associated interpretation statements IFRIC 4, SIC-15 and SIC-27. The new standard has affected the accounting for leases in the books of a lessee, whereas the accounting is in all material aspects remain unchanged for lessors. For Elekta, the major effect from implementing the new standard relates to leases for premises. IFRS 16 is effective for annual reporting periods beginning on or after 1 January 2019 and Elekta has applied the new standard from 1 May 2019.
The standard requires all lease arrangement to be recognized in the balance sheet with a few exceptions for shorttime leases and low-value leases.
Elekta has decided to apply IFRS 16 with the modified retrospective approach and as permitted by the standard the comparative period has not been restated. Instead an adjustment on the opening balance has shown the cumulative effect. The lease liabilities are measured at the present value of the remaining lease payments, discounted using the incremental borrowing rate at transition date. The weighted average incremental borrowing rate used at transition date was 3.85 %. Right-of-use assets are recognized based on the amount equal to the related lease liability.
IFRS 16 permits to use some practical expedients. Elekta has applied the following practical expedients when applying IFRS 16 at transition date:
Under the new standard the present value of lease obligations has been measured and reported as a non-current asset and interest-bearing liability in the Balance Sheet. The asset has been adjusted with prepaid rents and received incentives. In the Income Statement, lease payments previously reported as an operating expense within operating result have been replaced with depreciation and interest expenses. This change means that total assets and operating profit have increased, which has affected various key indicators. The cash flow from operations has increased related to the amortization of the lease liability, the amortization has instead been shown in the cash flow from financing activities.
According to the previous standard, IAS 17, there was a distinction between operating and finance lease arrangement, where operating leases were not recognized in the Balance Sheet. The value of undiscounted future lease fees is disclosed in note 9 in the Annual Report 2018/19, amounted to SEK 1459 M. The lease liability recognized in the Balance Sheet 1 May 2019 amounts to SEK 1220 M. The difference is mainly related to the discounting effect of the liability as the liability is calculated as the net present value for future payments, while the amount disclosed in note 9 is not discounted in accordance to IAS 17. Increases of the payments due to index and extension- and terminate options included in the lease liability does also explain the difference, together with the exclusion of lease payments related to low-value assets and short-term leases from the Balance Sheet. Those payments are expensed on a straight-line basis in the income statement.
| SEK M | Reported Apr 30, 2019 | Adjustment IFRS 16 | Adjusted May 1, 2019 |
|---|---|---|---|
| Right-of-use asset | 0 | 1,180 | 1,180 |
| Other assets | 24,064 | -20 | 24,044 |
| Total assets | 24,064 | 1,160 | 25,224 |
| Total equity | 7,779 | 0 | 7,779 |
| Long term lease liability | 0 | 1,020 | 1,020 |
| Short term lease liability | 0 | 200 | 200 |
| Other liabilities | 16,285 | -60 | 16,225 |
| Total equity and libilities | 24,064 | 1,160 | 25,224 |
Other new or revised standards and interpretations, not yet applied, are not considered to have a material impact on the Elekta Group´s financial statements.
Significant related-party transactions are described in note 35 in the Annual Report for 2018/19. No material changes have taken place in relations or transactions with related parties companies compared with the description in the Annual report 2018/19.
| Country | Currency | Average rate | Closing rate | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| May - Oct | Oct 31, | Apr 30, | ||||||||
| 2019/20 | 2018/19 | 1 Δ |
2019 | 2018 | 2019 | 1 Δ |
2 Δ |
|||
| Euroland | 1 EUR | 10.691 | 10.374 | 3% | 10.752 | 10.410 | 10.640 | 3% | 1% | |
| Great Britain | 1 GBP | 12.013 | 11.710 | 3% | 12.447 | 11.666 | 12.306 | 7% | 1% | |
| Japan | 1 JPY | 0.089 | 0.080 | 11% | 0.089 | 0.081 | 0.085 | 9% | 4% | |
| United States | 1 USD | 9.592 | 8.907 | 8% | 9.633 | 9.178 | 9.510 | 5% | 1% |
1 October 31, 2019 vs October 31, 2018
2 October 31, 2019 vs Apr 30, 2019
For Group companies with a functional currency other than Swedish kronor, order intake and income statements are translated at average exchange rates for the reporting period, while order backlog and balance sheets are translated at closing exchange rates.
Elekta applies geographical segmentation. Order intake, net sales and contribution margin for the respective regions are reported to Elekta's CFO and CEO (chief operating decision makers). The regions' expenses are directly attributable to the respective regions' reported figures including cost of products sold. Global costs for R&D, marketing, management of product supply centres and Parent Company are not allocated per region. Currency exposure is concentrated to product supply centres. The majority of exchange differences in operations are reported in global costs.
Elekta's operations are characterized by significant quarterly variations in volumes and product mix, which have a direct impact on net sales and profits. This is accentuated when the operation is split into segments, as is the impact of currency fluctuations between the years. Revenues from solutions are recognized at a point in time and revenues from services are recognized over time.
| SEK M | North and South America |
Europe, Middle East and Africa |
Asia Pacific |
Other / Group-wide |
Group total |
% of net sales |
|---|---|---|---|---|---|---|
| Net sales | 2,218 | 2,548 | 2,171 | - | 6,937 | |
| Regional expenses | -1,359 | -1,725 | -1,524 | - | -4,608 | 66% |
| Contribution margin | 860 | 823 | 647 | - | 2,330 | 34% |
| Contribution margin, % | 39% | 32% | 30% | |||
| Global costs | -1,773 | -1,773 | 26% | |||
| Operating result | 860 | 823 | 647 | -1,773 | 556 | 8% |
| Net financial items | -81 | -81 | ||||
| Profit before tax | 860 | 823 | 647 | -1,854 | 475 |
| North and South |
Europe, Middle East |
Asia | Other / | Group | % of net | |
|---|---|---|---|---|---|---|
| SEK M | America | and Africa | Pacific | Group-wide | total | sales |
| Net sales | 2,052 | 2,292 | 1,804 | - | 6,149 | |
| Regional expenses | -1,373 | -1,425 | -1,267 | - | -4,065 | 66% |
| Contribution margin | 680 | 867 | 537 | - | 2,084 | 34% |
| Contribution margin, % | 33% | 38% | 30% | |||
| Global costs | -1,454 | -1,454 | 24% | |||
| Operating result | 680 | 867 | 537 | -1,454 | 631 | 10% |
| Net financial items | -53 | -53 | ||||
| Profit before tax | 680 | 867 | 537 | -1,507 | 577 |
| North and South |
Europe, Middle East |
Asia | Other / | Group | % of net | |
|---|---|---|---|---|---|---|
| SEK M | America | and Africa | Pacific | Group-wide | total | sales |
| Net sales | 4,501 | 4,956 | 4,098 | - | 13,555 | |
| Regional expenses | -2,793 | -3,207 | -2,807 | - | -8,807 | 65% |
| Contribution margin | 1,707 | 1,749 | 1,291 | - | 4,748 | 35% |
| Contribution margin, % | 38% | 35% | 32% | |||
| Global costs | -3,052 | -3,052 | 23% | |||
| Operating result | 1,707 | 1,749 | 1,291 | -3,052 | 1,696 | 13% |
| Net financial items | -116 | -116 | ||||
| Profit before tax | 1,707 | 1,749 | 1,291 | -3,167 | 1,580 |
| SEK M | North and South America |
Europe, Middle East and Africa |
Asia Pacific |
Other / Group-wide |
Group total |
% of net sales |
|---|---|---|---|---|---|---|
| Net sales | 4,667 | 5,211 | 4,465 | - | 14,343 | |
| Regional expenses | -2,779 | -3,507 | -3,064 | - | -9,350 | 65% |
| Contribution margin | 1,888 | 1,704 | 1,402 | - | 4,993 | 35% |
| Contribution margin, % | 40% | 33% | 31% | |||
| Global costs | -3,372 | -3,372 | 24% | |||
| Operating result | 1,888 | 1,704 | 1,402 | -3,372 | 1,622 | 11% |
| Net financial items | -144 | -144 | ||||
| Profit before tax | 1,888 | 1,704 | 1,402 | -3,515 | 1,478 |
| Total | 2,218 | 2,548 | 2,171 | - | 6,937 | |
|---|---|---|---|---|---|---|
| Service | 1,267 | 951 | 613 | - | 2,831 | |
| Solutions | 952 | 1,596 | 1,558 | - | 4,107 | |
| SEK M | South America | and Africa | Asia Pacific | Group-wide | Group total | |
| North and | Middle East | Other / | ||||
| Europe, |
| Total | 2,052 | 2,292 | 1,804 | - | 6,149 | |
|---|---|---|---|---|---|---|
| Service | 1,127 | 836 | 550 | - | 2,513 | |
| Solutions | 925 | 1,457 | 1,254 | - | 3,636 | |
| SEK M | South America | and Africa | Asia Pacific | Group-wide | Group total | |
| North and | Middle East | Other / | ||||
| Europe, |
| Total | 4,501 | 4,956 | 4,098 | - | 13,555 |
|---|---|---|---|---|---|
| Service | 2,308 | 1,731 | 1,122 | - | 5,161 |
| Solutions | 2,192 | 3,224 | 2,977 | - | 8,394 |
| SEK M | South America | and Africa | Asia Pacific | Group-wide | Group total |
| North and | Middle East | Other / | |||
| Europe, |
| Total | 4,667 | 5,211 | 4,465 | - | 14,343 |
|---|---|---|---|---|---|
| Service | 2,448 | 1,847 | 1,184 | - | 5,479 |
| Solutions | 2,219 | 3,364 | 3,281 | - | 8,864 |
| SEK M | South America | and Africa | Asia Pacific | Group-wide | Group total |
| North and | Europe, Middle East |
Other / |
The table below shows the fair value of the Group's financial instruments, for which fair value is different than carrying value. The fair value of all other financial instruments is assumed to correspond to the carrying value.
| Oct 31, 2019 | Oct 31, 2018 | Apr 30, 2019 | ||||
|---|---|---|---|---|---|---|
| SEK M | Carrying amount |
Fair value |
Carrying amount |
Fair value | Carrying amount |
Fair value |
| Long-term interest-bearing liabilities | 3,137 | 3,309 | 4,422 | 4,416 | 3,558 | 3,573 |
| Long-term leasing liabilities | 1,038 | 1,038 | - | - | - | - |
| Short-term interest-bearing liabilities | 1,462 | 1,472 | 536 | 536 | 1,000 | 1,000 |
| Short-term leasing liabilities | 217 | 217 | - | - | - | - |
The Group's financial assets and financial liabilities, which have been measured at fair value, have been categorized in the fair value hierarchy. The different levels are defined as follows:
| SEK M | Level | Oct 31, 2019 | Oct 31, 2018 | Apr 30, 2019 |
|---|---|---|---|---|
| Financial assets | ||||
| Financial assets measured at fair value through profit or loss: | ||||
| Derivative financial instruments – non-hedge accounting | 2 | 49 | 17 | 70 |
| Short-term investments | 1 | 46 | 47 | 45 |
| Current investments classified as cash equivalents | 1 | 1,354 | - | 1,716 |
| Equity instruments | 1 | 58 | - | 58 |
| Equity instruments | 3 | 2 | - | 2 |
| Derivatives used for hedging purposes: | ||||
| Derivative financial instruments – hedge accounting | 2 | 27 | 1 | 2 |
| Total financial assets | 1,537 | 65 | 1,893 | |
| Financial liabilities | ||||
| Financial liabilities at fair value through profit or loss: | ||||
| Derivative financial instruments – non-hedge accounting | 2 | 25 | 30 | 25 |
| Contingent consideration | 3 | 53 | 3 | 2 |
| Derivatives used for hedging purposes: | ||||
| Derivative financial instruments – hedge accounting | 2 | 83 | 155 | 72 |
| Total financial liabilities | 162 | 188 | 99 |
| 1 May - Apr |
May - Apr | May - Oct | May - Oct | ||||
|---|---|---|---|---|---|---|---|
| 2014/15 | 2015/16 | 2016/17 | 2017/18 | 2018/19 | 2018/19 | 2019/20 | |
| Gross order intake, SEK M | 12,825 | 13,821 | 14,064 | 14,493 | 16,796 | 6,844 | 8,426 |
| Net sales, SEK M | 10,839 | 11,221 | 10,704 | 11,573 | 13,555 | 6,149 | 6,937 |
| Order backlog, SEK M | 17,087 | 18,239 | 22,459 | 27,974 | 32,003 | 29,126 | 33,581 |
| Operating result, SEK M | 937 | 423 | 598 | 1,845 | 1,696 | 631 | 556 |
| Operating margin, % | 8.6 | 3.8 | 5.6 | 15.9 | 12.5 | 10.3 | 8.0 |
| Profit margin, % | 6.6 | 1.7 | 3.2 | 14.5 | 11.7 | 9.4 | 6.9 |
| Shareholders' equity, SEK M | 6,646 | 6,412 | 6,774 | 6,987 | 7,779 | 6,970 | 7,898 |
| Return on shareholders' equity, % | 9 | 2 | 2 | 22 | 17 | 21 | 15 |
| Net debt, SEK M | 2,768 | 2,677 | 1,889 | 803 | 439 | 1,290 | 1,510 |
| Operational cash conversion, % | 126 | 111 | 145 | 95 | 61 | 12 | -18 |
| Average number of employees | 3,679 | 3,677 | 3,581 | 3,702 | 3,798 | 3,696 | 3,988 |
1 Calculation based on IAS18
| 1 May - Apr |
May - Apr | May - Oct | May - Oct | ||||
|---|---|---|---|---|---|---|---|
| 2014/15 | 2015/16 | 2016/17 | 2017/18 | 2018/19 | 2018/19 | 2019/20 | |
| Earnings per share | |||||||
| before dilution, SEK | 1.45 | 0.36 | 0.33 | 3.53 | 3.14 | 1.18 | 0.96 |
| after dilution, SEK | 1.45 | 0.36 | 0.33 | 3.53 | 3.14 | 1.18 | 0.96 |
| Cash flow per share | |||||||
| before dilution, SEK | 1.78 | 1.00 | 2.69 | 3.79 | 2.48 | -0.49 | -1.65 |
| after dilution, SEK | 1.78 | 1.00 | 2.69 | 3.79 | 2.48 | -0.49 | -1.65 |
| Shareholders' equity per share | |||||||
| before dilution, SEK | 17.41 | 16.79 | 17.73 | 18.29 | 20.36 | 18.24 | 20.67 |
| after dilution, SEK | 17.41 | 16.79 | 17.73 | 18.29 | 20.36 | 18.24 | 20.67 |
| Average number of shares | |||||||
| before dilution, 000s | 381,287 | 381,288 | 381,306 | 382,027 | 382,027 | 382,027 | 382,042 |
| after dilution, 000s | 381,287 | 381,288 | 381,306 | 382,027 | 382,027 | 382,027 | 382,042 |
| Number of shares at closing | |||||||
| before dilution, 000s 2 | 381,287 | 381,288 | 382,027 | 382,027 | 382,027 | 382,027 | 382,083 |
| after dilution, 000s | 381,287 | 381,288 | 382,027 | 382,027 | 382,027 | 382,027 | 382,083 |
1 Calculation based on IAS18
2 Number of registered shares at closing excluding treasury shares (1,485,289 per October 31, 2019).
| 2017/18 | 2018/19 | 2019/20 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| SEK M | Q2 | Q3 | Q4 | Q1 | Q2 | Q3 | Q4 | Q1 | Q2 |
| Gross order intake | 3,267 | 3,833 | 4,656 | 3,174 | 3,670 | 4,551 | 5,401 | 4,390 | 4,036 |
| Net sales | 2,903 | 2,756 | 3,409 | 2,819 | 3,330 | 3,320 | 4,086 | 3,228 | 3,709 |
| EBITA | 566 | 534 | 848 | 386 | 601 | 505 | 985 | 448 | 539 |
| Operating result | 440 | 409 | 714 | 238 | 393 | 311 | 755 | 236 | 321 |
| Cash flow from operating activities |
403 | 691 | 1,235 | -381 | 512 | -57 | 1,547 | -629 | 419 |
| 2017/18 | 2018/19 | 2019/20 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Q2 | Q3 | Q4 | Q1 | Q2 | Q3 | Q4 | Q1 | Q2 | |
| North and South America, % | 14 | 15 | 10 | 23 | -41 | 16 | 9 | 0 | 29 |
| Europe, Middle East and Africa, % | - 5 |
- 5 |
28 | 15 | 43 | 5 | 18 | 64 | -21 |
| Asia Pacific, % | -11 | 33 | - 9 |
2 | 18 | 20 | - 8 |
31 | 23 |
| Group, % | 0 | 9 | 10 | 12 | 2 | 12 | 8 | 32 | 5 |
Alternative Performance Measures (APMs) are measures and key figures that Elekta's management and other stakeholders use when managing and analysing Elekta's business performance. These measures are not substitutes, but rather supplements to financial reporting measures prepared in accordance with IFRS. Key figures and other APMs used by Elekta are defined on www.elekta.com/investors/financials/definitions.php. Definitions and additional information on APMs can also be found on pages 122-124 in the Annual Report 2018/19.
Elekta's order intake and sales are, to a large extent, reported in subsidiaries with other functional currencies than SEK, which is the group reporting currency. In order to present order and sales growth on a more comparable basis and to show the impact of currency fluctuations, order and sales growth based on constant exchange rates are presented. The schedules below present growth based on constant exchange rates reconciled to the total growth reported in accordance with IFRS.
| Europe, | ||||||||
|---|---|---|---|---|---|---|---|---|
| North and South America |
Middle East, and Africa |
Asia Pacific | Group total |
|||||
| % | SEK M | % | SEK M | % | SEK M | % | SEK M | |
| Q2 2019/20 vs. Q2 2018/19 | ||||||||
| Change based on constant exchange rates | 29 | 250 | -21 | -337 | 23 | 271 | 5 | 184 |
| Currency effects | 9 | 77 | 0 | - 1 |
9 | 107 | 5 | 183 |
| Reported change | 37 | 327 | -21 | -338 | 31 | 378 | 10 | 366 |
| Q2 2018/19 vs. Q2 2017/18 | ||||||||
| Change based on constant exchange rates | -41 | -536 | 43 | 434 | 18 | 166 | 2 | 64 |
| Currency effects | 7 | 90 | 15 | 151 | 10 | 97 | 10 | 338 |
| Reported change | -34 | -445 | 58 | 585 | 28 | 263 | 12 | 403 |
| May - Oct 2019/20 vs. May - Oct 2018/19 | ||||||||
| Change based on constant exchange rates | 13 | 248 | 12 | 309 | 26 | 631 | 17 | 1,188 |
| Currency effects | 8 | 153 | 2 | 58 | 8 | 183 | 6 | 394 |
| Reported change | 21 | 401 | 14 | 367 | 34 | 814 | 23 | 1,582 |
| May - Oct 2018/19 vs. May - Oct 2017/18 | ||||||||
| Change based on constant | ||||||||
| exchange rates | -17 | -353 | 30 | 548 | 9 | 183 | 6 | 378 |
| Currency effects | 5 | 107 | 12 | 216 | 7 | 138 | 8 | 461 |
| Reported change | -12 | -246 | 42 | 765 | 16 | 320 | 14 | 839 |
| Europe, | ||||||||
|---|---|---|---|---|---|---|---|---|
| North and South America |
Middle East, and Africa |
Asia Pacific | Group total |
|||||
| % | SEK M | % | SEK M | % | SEK M | % | SEK M | |
| Q2 2019/20 vs. Q2 2018/19 | ||||||||
| Change based on constant | ||||||||
| exchange rates | 1 | 13 | 8 | 102 | 13 | 121 | 7 | 236 |
| Currency effects | 7 | 80 | 0 | - 2 |
7 | 65 | 4 | 143 |
| Reported change | 8 | 93 | 8 | 100 | 20 | 186 | 11 | 379 |
| Q2 2018/19 vs. Q2 2017/18 | ||||||||
| Change based on constant | ||||||||
| exchange rates | 5 | 46 | 6 | 73 | 6 | 46 | 6 | 165 |
| Currency effects | 10 | 100 | 9 | 96 | 8 | 65 | 9 | 262 |
| Reported change | 15 | 146 | 15 | 169 | 14 | 111 | 15 | 427 |
| May - Oct 2019/20 vs. May - Oct 2018/19 | ||||||||
| Change based on constant | ||||||||
| exchange rates | 1 | 10 | 10 | 233 | 14 | 247 | 8 | 490 |
| Currency effects | 8 | 156 | 1 | 22 | 7 | 120 | 5 | 299 |
| Reported change | 8 | 166 | 11 | 255 | 20 | 367 | 13 | 789 |
| May - Oct 2018/19 vs. May - Oct 2017/18 | ||||||||
| Change based on constant | ||||||||
| exchange rates | 1 | 28 | 8 | 168 | 14 | 207 | 7 | 404 |
| Currency effects | 6 | 115 | 7 | 142 | 5 | 81 | 6 | 338 |
| Reported change | 7 | 143 | 16 | 310 | 19 | 288 | 14 | 742 |
EBITDA is used for the calculation of operational cash conversion and the net debt/EBITDA ratio.
| SEK M | Q2 2018/19 | Q3 2018/19 | Q4 2018/19 | Q1 2019/20 | Q2 2019/20 |
|---|---|---|---|---|---|
| Operating result/EBIT | 393 | 311 | 755 | 236 | 321 |
| Amortization: | |||||
| Capitalized development costs | 176 | 167 | 200 | 184 | 187 |
| Assets relating business combinations | 32 | 27 | 30 | 28 | 32 |
| Depreciation | 38 | 40 | 42 | 95 | 95 |
| EBITDA | 639 | 545 | 1,028 | 542 | 634 |
Return on capital employed is a measure of the profitability after taking into account the amount of total capital used unrelated to type of financing. A higher return on capital employed indicates a more efficient use of capital. Capital employed represents the value of the balance sheet net assets that is the key driver of cash flow and capital required to run the business. It is also used in the calculation of return on capital employed.
| SEK M | Oct 31, 2018 | Jan 31, 2019 | Apr 30, 2019 | Jul 31, 2019 | Oct 31, 2019 |
|---|---|---|---|---|---|
| Profit before tax (12 months rolling) | 1,609 | 1,504 | 1,580 | 1,558 | 1,478 |
| Financial expenses (12 months rolling) | 220 | 211 | 186 | 211 | 227 |
| Profit before tax plus financial expenses | 1,829 | 1,715 | 1,766 | 1,769 | 1,705 |
| Total assets | 22,645 | 22,685 | 24,064 | 24,855 | 25,239 |
| Deferred tax liabilities | -537 | -537 | -587 | -574 | -584 |
| Long-term provisions | -172 | -165 | -188 | -194 | -211 |
| Other long-term liabilities | -84 | -57 | -55 | -10 | -55 |
| Accounts payable | -1,111 | -1,082 | -1,427 | -1,226 | -1,270 |
| Advances from customers | -4,652 | -4,850 | -4,883 | -4,652 | -4,777 |
| Prepaid income | -1,910 | -2,010 | -2,170 | -2,108 | -2,065 |
| Accrued expenses | -1,570 | -1,596 | -1,661 | -1,539 | -1,732 |
| Current tax liabilities | -112 | -93 | -166 | -143 | -184 |
| Short-term provisions | -157 | -148 | -188 | -184 | -185 |
| Derivative financial instruments | -153 | -57 | -94 | -243 | -108 |
| Other current liabilities | -258 | -333 | -308 | -354 | -316 |
| Capital employed | 11,928 | 11,756 | 12,337 | 13,629 | 13,752 |
| Average capital employed (last five quarters) | 11,628 | 11,786 | 12,010 | 12,269 | 12,680 |
| Return on capital employed | 16% | 15% | 15% | 14% | 13% |
Return on shareholders' equity measures the return generated on shareholders' capital invested in the company.
| SEK M | Q2 2018/19 | Q3 2018/19 | Q4 2018/19 | Q1 2019/20 | Q2 2019/20 |
|---|---|---|---|---|---|
| Net income (12 months rolling) | 1,294 | 1,164 | 1,198 | 1,180 | 1,116 |
| Average shareholders' equity excluding | |||||
| non-controlling interests (last five quarters) | 6,554 | 6,842 | 7,167 | 7,339 | 7,549 |
| Return on shareholders' equity | 20% | 17% | 17% | 16% | 15% |
Cash flow is a focus area for management. The operational cash conversion shows the relation between cash flow from operating activities and EBITDA.
| SEK M | Q2 2018/19 | Q3 2018/19 | Q4 2018/19 | Q1 2019/20 | Q2 2019/20 |
|---|---|---|---|---|---|
| Cash flow from operating activities |
512 | -57 | 1,547 | -629 | 419 |
| EBITDA | 639 | 545 | 1,028 | 542 | 634 |
| Operational cash conversion | 80% | -10% | 151% | -116% | 66% |
In Order to optimize cash generation, management focuses on working capital and reducing lead times between orders booked and cash received.
| SEK M | Oct 31 2019 |
Oct 31 2018 |
Apr 30 2019 |
|---|---|---|---|
| Working capital assets | |||
| Inventories | 3,048 | 2,463 | 2,634 |
| Accounts receivable | 3,529 | 2,982 | 3,455 |
| Accrued income | 1,356 | 1,420 | 1,401 |
| Other operating receivables | 1,442 | 1,166 | 1,059 |
| Sum working capital assets | 9,374 | 8,031 | 8,548 |
| Working capital liabilities | |||
| Accounts payable | 1,270 | 1,111 | 1,427 |
| Advances from customers | 4,777 | 4,652 | 4,883 |
| Prepaid income | 2,065 | 1,910 | 2,170 |
| Accrued expenses | 1,732 | 1,570 | 1,661 |
| Short-term provisions | 185 | 157 | 188 |
| Other current liabilities | 316 | 258 | 308 |
| Sum working capital liabilities | 10,345 | 9,659 | 10,638 |
| Net working capital | -971 | -1,628 | -2,089 |
| % of 12 months net sales | -7% | -13% | -15% |
Net debt is important for understanding the financial stability of the company. Net debt and net debt/EBITDA ratio are used by management to track the debt evolvement, the refinancing need and the leverage for the Group.
| SEK M | Oct 31, 2018 | Jan 31, 2019 | Apr 30, 2019 | Jul 31, 2019 | Oct 31, 2019 |
|---|---|---|---|---|---|
| Long-term interest-bearing liabilities | 4,422 | 4,463 | 3,558 | 3,504 | 3,137 |
| Short-term interest-bearing liabilities | 536 | 38 | 1,000 | 1,015 | 1,462 |
| Cash and cash equivalents and short-term | |||||
| investments | -3,669 | -2,980 | -4,119 | -3,349 | -3,090 |
| Net debt | 1,290 | 1,521 | 439 | 1,170 | 1,510 |
| EBITDA (12 months rolling) | 2,522 | 2,499 | 2,639 | 2,754 | 2,750 |
| Net debt/EBITDA ratio | 0.51 | 0.61 | 0.17 | 0.42 | 0.55 |
On November 15, Elekta published preliminary results for the second quarter and updated outlook of EBITA margin from around 19 percent, to around 18 percent, for fiscal year 2019/20.
Elekta will host a live presentation and a web/telephone conference at 10:00-11:00 CET on November 28 with president and CEO Dr Richard Hausmann, and CFO Gustaf Salford. To take part of the presentation please welcome to the HQ, dial the numbers below or watch via the web link below.
Swedish dial-in-no.: +46 8 505 583 58 UK dial-in no.: +44 33 330 090 34 US dial-in no.: +1 833 823 05 89
https://elekta-qreports.creo.se/191128/elekta\_q2\_brpresentation\_and\_conference\_call
| Interim report, Q3, May-Jan 2019/20 | February 20, 2020 |
|---|---|
| Year-end report 2019/20 | May 29, 2020 |
For almost five decades, Elekta has been a leader in precision radiation medicine. Our nearly 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to – and benefits from – more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit elekta.com or follow @Elekta on Twitter.
CFO Elekta AB (publ) +46 702 16 17 50 [email protected]
Head of Investor Relations Elekta AB (publ) +46 76 611 76 25 [email protected]


Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.